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Abstract Cyclin-dependent kinase 5 (Cdk5) in association with
its neuronal activators p35 and p39 shows a complex involve-
ment in the control of neurocytoskeletal dynamics. Here we
show that K-chimaerin, a GTPase-activating protein speci¢c
for Rac and Cdc42, is a p35-binding protein. The interaction
domains of p35 and K-chimaerin were delineated. In transfected
HeLa cells, p35 and K-chimaerin displayed an overlapping dis-
tribution pattern and they could be co-immunoprecipitated from
the cell lysate. As K-chimaerin has a regulatory function in actin
repolymerization, these results suggested that the regulation of
neurocytoskeleton dynamics by Cdk5 is mediated at least in
part via K-chimaerin.
- 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
As a unique member of the CDK family, cyclin-dependent
kinase 5 (Cdk5) is highly enriched in neurons of mammalian
central nervous tissues. Along with its neuron-speci¢c activa-
tors, p35 and p39, Cdk5 plays key roles in a variety of neuro-
nal functions [1]. In mammalian brain extracts, Cdk5 and its
activators are present in macromolecular complexes with mul-
tiple protein components [2]. Over the last few years, a large
number of Cdk5-p35-binding proteins have been identi¢ed by
yeast two-hybrid screens or proteomic analyses, implicating
the kinase in diverse cellular processes in neurons (see [3]
for a review). In particular, many of the binding proteins
are cytoskeletal proteins including protein subunits of neuro-
¢laments (neuro¢lament heavy chain NF-H and middle chain
NF-M), actin ¢laments and cytoskeleton-regulatory proteins
such as tau and K-actinin 1 [4^6]. In addition, Rac1, which is
a small GTPase protein implicated in the regulation of actin
cytoskeletons, was shown to be a p35-binding protein [7].
These ¢ndings suggested that Cdk5 plays important roles in
neurocytoskeleton dynamics. However, the molecular mecha-
nism underlying Cdk5 actions is highly complex and far from
clear.
Rac1 is a member of the Rho small GTPase family and
implicated in signal pathways of neuronal growth cone activ-
ity [8]. The active form of Rac1 (GTP-bound form) is capable
of activating a protein Ser/Thr kinase, PAK1, to induce re-
modeling of actin ¢laments, thus leading to the formation of
lamellipodia and membrane ru¥es. PAK1 is a substrate of
Cdk5; phosphorylation of PAK1 by Cdk5 results in the in-
activation of PAK1 [7]. All Rho family members possess in-
trinsic GTP hydrolysis activity that is stimulated by GTPase-
activating proteins (GAPs), which convert the Rho members
from the active form to the inactive form (GDP-bound form).
In the present study, we have identi¢ed K-chimaerin, a GAP
for Rac1 and Cdc42 [9,10], as a p35-binding protein in a yeast
two-hybrid screen and demonstrated the interaction of K-chi-
maerin and p35-Cdk5 both in vitro and inside cultured cells.
K-Chimaerin mediates actin cytoskeleton dynamics in a Rac1/
Cdc42-dependent manner [11,12]. Results presented here sug-
gest that K-chimaerin and Cdk5-p35 act cooperatively in Rac1
signaling pathways to modulate actin remodeling in neuronal
growth cones.
2. Materials and methods
2.1. Yeast two-hybrid assay
The yeast two-hybrid system was employed as described in previous
reports [4,13]. To search for p35-interacting proteins, p35 (SwissProt
accession number Q28199) was engineered in the vector pAS2 (Clon-
tech) as a bait and the prey is a human brain cDNA library con-
structed in pACT2 (Clontech). The bait and the prey were co-trans-
formed into the yeast reporter strain CG-1945 for the interaction
hunt. To test the interaction between K-chimaerin (SwissProt acces-
sion number P15882) and various p35 fragments, the p35-binding
fragment of K-chimaerin in pACT2 and the p35 fragments in pAS2
were co-expressed in the yeast strain Y190 for reporter assays. Cdk5
(SwissProt accession number Q00535) and p39 (SwissProt accession
number Q13319) were also subcloned into pAS2 for the interaction
test.
2.2. Plasmid construction and recombinant protein preparation
The sequence of K1-chimaerin (SwissProt accession number P15882)
was ampli¢ed by a polymerase chain reaction from a human brain
cDNA library and engineered into the vector pGEX-KT. Recombi-
nant proteins in fusion with glutathione S-transferase (GST) or His6
were prepared as described previously [13,14]. To remove GST from
the fusion proteins, glutathione (GSH) beads coupled with the GST
proteins were suspended in the cleavage bu¡er containing 25 mM
Tris^HCl, pH 7.5, 1 mM dithiothreitol (DTT), 0.15 M NaCl, and
thrombin (Sigma). The cleavage was carried out at room temperature
for 2 h. The beads were then removed by centrifugation. Supernatant
was subjected to incubation with benzamidine-Sepharose (Sigma) at
4‡C for 1 h to absorb thrombin. After the incubation, the beads were
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pelleted by centrifugation to collect supernatant, which contained the
GST-free recombinant proteins.
2.3. Biochemical binding assay
GST-K1-chimaerin was mixed and incubated with the recombinant
proteins of Cdk5 and p35 in the binding bu¡er (25 mM Tris, pH 7.5,
1 mM DTT, 0.1 M NaCl, 0.1% Triton X-100 and 5 mg/ml bovine
serum albumin) at 4‡C for 1 h. GSH beads were then added for a
further incubation at 4‡C for 1 h to capture GST. The beads were
then retrieved and washed extensively with the binding bu¡er. Pro-
teins bound to the beads were dissolved in the sodium dodecyl sul-
fate^polyacrylamide gel electrophoresis (SDS^PAGE) sample loading
bu¡er and subjected to immunoblotting using the antibodies of anti-
p35 (C-19, Santa Cruz Biotech), anti-Cdk5 (C-8, Santa Cruz Biotech)
and anti-His6 (Amersham Pharmacia Biotech). Competitive binding
assays were performed by incubating GST-K1-chimaerin and His6-
p35(145^170) with increasing amounts of the His6-tagged C48K1 frag-
ment of protein C48 (SwissProt accession number Q9JLH5). After the
pull-down of GST-K1-chimaerin using GSH beads, bound His6-
p35(145^170) was determined by immunoblotting.
2.4. Protein phosphorylation
Phosphorylation of K1-chimaerin was carried out at 30‡C for 30
min. Reactions contained 20 mM MOPS, pH 7.5, 5 mM MgCl2,
100 WM [Q-32P]ATP (V5000 dpm/pmol), 1 mM DTT, 1 Wg K1-chi-
maerin and Cdk5-p25. The reaction was terminated by the addition of
the SDS^PAGE sample loading bu¡er and boiling for 5 min. Proteins
were then resolved on SDS^PAGE. Protein phosphorylation was vi-
sualized on autoradiograph.
2.5. Cell transfection, immunoprecipitation and immunostaining
HeLa cells were cultured in Dulbecco’s modi¢ed Eagle’s medium
containing 10% fetal calf serum. Cells were transfected using the cal-
cium phosphate precipitation method at 40^60% con£uence with 10
Wg of plasmid DNA for a 100-mm plate. At 24 h post transfection, the
cells were scraped from their plates and lysed in 1 ml of the ice-cold
lysis bu¡er (50 mM HEPES, pH 7.2, 250 mM NaCl, 0.1% NP-40,
1 mM EDTA, 1 mM EGTA, 5 mM NaF, 1 mM DTT, 10 Wg/ml
leupeptin, 1 Wg/ml antipain, 2 mM phenylmethylsulfonyl £uoride
and 100 Wg/ml benzamidine) for 15 min at 4‡C. Cell debris were
then removed by centrifugation (15 min at 14 000Ug).
Aliquots of the cell lysates (100 Wg/Wl) were diluted with phosphate-
bu¡ered saline (PBS) and incubated with the anti-p35 antibody for 2 h
at 4‡C, followed by 1 h incubation with 50 Wl of 50% slurry of protein
G-agarose beads. The beads were washed four times with PBS and
bound proteins were released by the addition of the SDS^PAGE
sample loading bu¡er and boiling. For immunostaining, transfected
cells were washed with PBS, ¢xed in 4% paraformaldehyde for 15 min,
washed, and permeabilized with absolute methanol for 2 min. Primary
antibodies (the anti-p35 antibody and the anti-HA monoclonal anti-
body 12CA5 at 1:50 and 1:60 dilutions respectively in PBS containing
3% bovine serum albumin) were added to the slide and stained for 1 h
at room temperature. Likewise, secondary antibodies were added after
removal of the primary antibodies by PBS washing. The cells were
then visualized using confocal microscopy.
3. Results
3.1. Physical association of K-chimaerin and the neuronal Cdk5
kinase
As described in our earlier reports [4,13], the yeast two-
hybrid system was employed to search for p35-binding pro-
teins in a human brain cDNA library. One of the isolates was
found to contain a sequence encoding the C-terminal 98 ami-
no acid residues of K1- and K2-chimaerin. To further test the
binding of K-chimaerin to p35, various truncated forms of p35
were examined for their ability to associate with the isolated
K-chimaerin fragment. Two-hybrid assay results indicated that
the interaction occurs within p25, which is the proteolytically
truncated form of p35 existing in cells under neurotoxic con-
ditions (Fig. 1) [15^17]. The assays of further truncated p35
fragments showed that the K-chimaerin-binding activity is re-
tained in p35(145^291), but not in the shorter fragment
p35(150^291) (Fig. 1). Mammalian nervous systems contain
p39, which is a p35 homolog and displays a similar activity to
activate Cdk5 speci¢cally [18]. In our yeast two-hybrid assays,
p39 is also capable of associating with K-chimaerin (data not
shown). In addition, Cdk5 did not show any detectable inter-
action with the isolated K-chimaerin fragment in the two-hy-
brid assay (data not shown).
Direct binding of K-chimaerin to p35 was validated in a
biochemical binding assay using recombinant proteins of
p35 and K1-chimaerin. Incubation of p35-His6 with GST-K1-
chimaerin followed by a⁄nity precipitation of GST-K1-chi-
maerin resulted in the co-precipitation of p35 as revealed on
Fig. 1. Interaction of p35 and its fragments with K-chimaerin in the
yeast two-hybrid assay. p35 fragments in pAS2 and the C-terminal
98 amino acids of K-chimaerin in pACT2 were co-transformed into
the yeast Y190 for the reporter assays.
Fig. 2. Biochemical binding assay of K-chimaerin and Cdk5-p35. A:
Binding of GST-K1-chimaerin and His6-tagged p35 proteins. GST
or GST-K1-chimaerin (30 Wg) was incubated with 15 Wg of the indi-
cated His6-tagged p35 proteins at 4‡C for 1 h. The GST proteins
were then retrieved using GSH beads. Co-precipitated p35 proteins
were detected by Western blots using the anti-His6 antibody. B:
Schematic representation of the functional regions of p35. C: K-Chi-
maerin competes with C48 in binding to p35. GST-K1-chimaerin (30
Wg) was incubated with His6-p35(145^170) (15 Wg) in the presence
of increasing amounts of the C48 fragment C48K1. After the pull-
down of GST-K1-chimaerin with GSH beads, the amounts of His6-
p35(145^170) bound to the beads were determined by an anti-His6
immunoblot.
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immunoblots (Fig. 2A, upper panel). In the control assay, p35
was not detected in the precipitate of GST, indicating the
speci¢c binding of p35 and K1-chimaerin. A short peptide
spanning the residues 145^170 of p35 was previously identi¢ed
as the region for the competitive binding of at least three
proteins, C42, C48 and C53 [14]. Given the yeast two-hybrid
result that K-chimaerin binds to a region located within 145^
291 amino acids of p35, the 145^170-amino acid fragment was
tested in the pull-down of GST-K1-chimaerin. Results indi-
cated that this short region of p35 is capable in binding to
K1-chimaerin (Fig. 2A, lower panel). Fig. 2B is a schematic
graph of the binding fragments of p35. Further, when the K1
fragment of protein C48 was applied at increasing amounts in
the binding assays, it competed o¡ GST-K1-chimaerin from
the p35(145^170) association (Fig. 2C). Taken together, K-
chimaerin binds p35 in the same region as C42, C48 and
C53 and competes with these proteins in the p35 association.
3.2. The complex of K-chimaerin, Cdk5 and p35 is
enzymatically functional
In brain, p35 or p25 exists with and activates Cdk5. It is
therefore important to examine whether K-chimaerin can bind
to the p25- or p35-Cdk5 complex. Using GST-K1-chimaerin,
we performed the pull-down assays and found that both p35
and Cdk5 could be co-precipitated by K1-chimaerin. More-
over, there are two potential Cdk5 phosphorylation sites in
the K1-chimaerin sequence [19,20], and in an in vitro phos-
phorylation reaction K1-chimaerin was readily phosphorylated
by Cdk5-p25 (Fig. 3A), suggesting that K1-chimaerin is a po-
tential physiological substrate of Cdk5. To investigate
whether the K1-chimaerin phosphorylation a¡ects its associa-
tion with Cdk5-p25, the pull-down assay was performed
under the phosphorylation condition. As shown in Fig. 3B,
GST-K1-chimaerin precipitated the same amount of Cdk5-p25
under both the non-phosphorylating and phosphorylating
conditions, indicating that the K1-chimaerin association is
not mediated by the K1-chimaerin phosphorylation.
Next, we examined the potential e¡ects of K-chimaerin on
the Cdk5 activation. Cdk5 can be highly activated by recon-
stitution with p35 or its truncated form p25 [15,21]. In our
tests, the Cdk5 kinase was reconstituted from recombinant
Cdk5 and p25 proteins in the presence or absence of K1-chi-
maerin. Kinase assays showed that K1-chimaerin had no
marked e¡ect on the Cdk5 activation by p25 even when K1-
chimaerin was present in excess (data not shown). On the
other hand, K-chimaerin is a GAP to enhance the intrinsic
GTPase activity of Rac1 or Cdc42. In order to determine
whether the Cdk5-p35 association a¡ects its GAP activity, a
GTPase assay was performed according to the published pro-
tocols to measure the GAP activity of K1-chimaerin towards
Rac1 [22,23]. From the assays, K1-chimaerin that was prein-
cubated with or without an excessive amount of Cdk5-p25 did
not show any detectable di¡erence in its GAP activity (data
not shown), indicating that the association of Cdk5-p25 does
Fig. 3. The Cdk5 kinase is enzymatically active in the complex of
K-chimaerin. A: Phosphorylation of K1-chimaerin by Cdk5. 1 Wg of
K1-chimaerin was subjected to phosphorylation reactions in the pres-
ence or absence of Cdk5-p25. After incubation at 30‡C for 30 min,
reactions were terminated by boiling in the SDS^PAGE sample
loading bu¡er. Proteins were then resolved by SDS^PAGE to visu-
alize protein phosphorylation by autoradiography. B: The K1-chi-
maerin phosphorylation does not a¡ect its association with the
Cdk5 kinase. 10 Wg of GST-K1-chimaerin was incubated with the
Cdk5-p25 complex in the presence or absence of ATP-Mg2þ at
30‡C for 30 min. GST was used in the control in place of GST-K1-
chimaerin. After the GST proteins were recovered with GSH beads,
bound proteins were immunoblotted using the anti-Cdk5 and anti-
p35 antibodies.
Fig. 4. Co-localization of K2-chimaerin and p35 in transfected cells.
HeLa cells were co-transfected with plasmids expressing p35 and
HA-K2-chimaerin. Double immunostaining was performed on the
transfected cells with the anti-HA (red) and anti-p35 (green) anti-
bodies. The merged image shows the region of co-localization in yel-
low.
Fig. 5. In vivo association of K-chimaerin and Cdk5-p35. HeLa cells
were singly transfected with the construct expressing HA-K2-chi-
maerin or doubly transfected with the HA-K2-chimaerin and p35
constructs. A: The expression of HA-K2-chimaerin and p35 was ex-
amined in the cell lysates by Western blotting using anti-HA and
anti-p35 antibodies, respectively. B: Immunoprecipitation was per-
formed using the anti-p35 antibody or non-speci¢c IgG from the
cell lysates containing 500 Wg proteins. The immunoprecipitates
were probed on Western blots with the anti-HA and anti-p35 anti-
bodies. The Cdk5 kinase activity in the immunoprecipitates was
measured with (solid bar) and without (empty bar) adding the exog-
enous GST-Cdk5 protein (0.6 Wg).
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not a¡ect the GAP activity of K-chimaerin. Thus, it is tempt-
ing to conclude from these results that Cdk5, p35 and K-chi-
maerin form a ternary protein complex with both the kinase
and GAP activities.
3.3. K-Chimaerin associates with the neuronal Cdk5 kinase in
vivo
To examine the cellular localizations of K-chimaerin and
p35, immuno£uorescent staining was performed. HeLa cells
were doubly transfected with the constructs expressing p35
and K2-chimaerin. Using the antibodies, the K2-chimaerin pro-
tein was found to localize predominantly in cytoplasm and
plasma membranes, displaying a very similar pattern to that
of p35 (Fig. 4). Co-localization of p35 and K2-chimaerin was
observed mainly in the plasma membrane region (Fig. 4). In
order to determine their association in the cells, the cell lysates
that contained similar amounts of the expressed proteins were
selected for the immunoprecipitation experiment (Fig. 5A).
Fig. 5B shows that the HA-K2-chimaerin protein was co-pre-
cipitated with p35 from the co-transfected lysate, whereas the
negative controls, which are the p35 immunoprecipitation
from the singly transfected HA-K2-chimaerin lysate and the
non-speci¢c IgG immunoprecipitation from the p35 and K2-
chimaerin co-transfected lysate, did not precipitate any K2-
chimaerin protein. Moreover, when the immunoprecipitates
were assayed for Cdk5 activity with or without added GST-
Cdk5 protein, the K2-chimaerin-p35 co-immunoprecipitate ex-
hibited endogenous Cdk5 kinase activity, which can be further
activated by the addition of the exogenous Cdk5 protein (Fig.
5B), corroborating the results of in vitro reconstitution assays
that p35 and Cdk5 can form an enzymatically active complex
with K-chimaerin.
4. Discussion
Here, using the yeast two-hybrid system, K-chimaerin was
identi¢ed to interact with the p35 activator of Cdk5. In vitro
studies demonstrated the association of K-chimaerin with
Cdk5-p35 to form a ternary protein complex. The K-chimaer-
in interaction was located in p35 to a short peptide spanning
the residues 145^170. Given the facts that this region interacts
with the C42, C48 and C53 proteins in a competitive manner
and C48 exhibited competition with K1-chimaerin in the bind-
ing assay [14], C42, C48 and C53 could mediate the associa-
tion of p35 and K-chimaerin in vivo.
K-Chimaerin exists as two alternatively spliced variants, K1-
and K2-chimaerins, sharing the structure of a cysteine-rich
domain followed by the GAP domain [20]. The di¡erence
between the two variants lies at the N-terminus with a SH2
domain in K2- but not in K1-chimaerin. The isolated p35-bind-
ing sequence comprises the C-terminal 98 amino acids of both
K1- and K2-chimaerins, which overlaps the GAP domain. The
two forms of K-chimaerin have slightly di¡erent expression
patterns in brain and the expression of K2-chimaerin was
found to resemble that of p35 [11]. In the transfected cells,
K2-chimaerin displayed an overlapping localization pattern
with p35 and the two proteins as well as Cdk5 could be co-
immunoprecipitated from the cell lysate. These results sug-
gested that K-chimaerin, Cdk5 and p35 exist in a complex in
neurons. Moreover, both the kinase activity of Cdk5 and the
GAP activity of K-chimaerin are retained in the protein com-
plex. Meanwhile, the protein complex may contain additional
protein molecules such as Rac1 and PAK1 [7,11]. Although
the functional signi¢cance of the protein complex is unclear
yet, the possibility that various activities in the complex are
coordinated in the regulation of actin dynamics may be con-
sidered. For example, K-chimaerin may facilitate locating the
Cdk5 kinase to its targets in the signaling pathways. On the
other hand, K-chimaerin, by facilitating the conversion of
Rac1 from the GTP- to GDP-bound form [9,10], and Cdk5,
by phosphorylating and inhibiting PAK1 [7], bring about the
down-regulation of the Rac1 signaling. Thus, the association
of K-chimaerin and Cdk5-p35 may be required for their coor-
dinated involvements in remodeling of actin ¢laments.
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